Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Travel grant 2024 Schweiz, Swiss Nordic Bio 2024 den 7mars

Reference number
Coordinator Cline Scientific AB
Funding from Vinnova SEK 15 000
Project duration March 2024 - March 2024
Status Completed
Venture Global cooperation 2024

Important results from the project

** Denna text är maskinöversatt ** Cline Scientific develops advanced cancer diagnostics and stem cell therapies. Cline is pushing two project into clinical phase, StemCART - a stem cell-based therapy for cartilage repair, and CellRACE - a cancer diagnostic product to predict metastasis. Hanne Evenbratt, VP of R&D, traveled to the conference in Switzerland. Several contacts were made with investors and other types of collaboration partners in 1-to-1 meetings as well as mingling during breaks. Cline Scientific was presented under Investor & Partnering Pitches.

Expected long term effects

** Denna text är maskinöversatt ** Cline´s goals were met.

Approach and implementation

** Denna text är maskinöversatt ** The objective that were set before the trip were well balanced and all objectives were achieved. Unfortunately, the journey home was forced to start earlier than planned as the flight strike in Germany caused the planned journey to be cancelled. Despite this, the goals were met.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 29 March 2024

Reference number 2024-00372